PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
5.26%
Net income growth under 50% of VUZI's 11.25%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
3.57%
Less D&A growth vs. VUZI's 22.92%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
500.00%
Deferred tax of 500.00% while VUZI is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
No Data
No Data available this quarter, please select a different quarter.
-1916.67%
Both reduce yoy usage, with VUZI at -19.64%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-356.25%
Both yoy AR lines negative, with VUZI at -73.35%. Martin Whitman would suspect an overall sector lean approach or softer demand.
75.00%
Inventory growth well above VUZI's 80.56%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
441.38%
A yoy AP increase while VUZI is negative at -192.98%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
-566.67%
Negative yoy usage while VUZI is 352.14%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
110.00%
Well above VUZI's 100.00%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-95.24%
Both yoy CFO lines are negative, with VUZI at -38.64%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-19.44%
Both yoy lines negative, with VUZI at -18.60%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-100.00%
Negative yoy acquisition while VUZI stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-9.62%
Negative yoy purchasing while VUZI stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-21.80%
We reduce yoy sales while VUZI is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-520.00%
We reduce yoy other investing while VUZI is 6.90%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-97.84%
Both yoy lines negative, with VUZI at -13.57%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
227.27%
Stock issuance far above VUZI's 124.06%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
No Data
No Data available this quarter, please select a different quarter.